Tubugi-1 (a small cytotoxic peptide-SS-NPY disulfide-linked conjugate) has been used to treat tumor cancer cells overexpressing Y1R (e.g., HT-29 and Colo320 (colon cancer cells), PC-3 (prostate cancer cells)). Here, NPY is linked to prostate carcinoma.